CLINICAL DIRECTOR SOLUTIONS LTDActive

Company number 07155983Private limited companyIncorporated 2010

Key figures

£358,376+4.2%
Net assets 2025/26
+11.7%
Average annual growth 2019/20–2025/26
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, CLINICAL DIRECTOR SOLUTIONS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand————434,760
Total assets331,600403,452418,936436,193453,478
Total liabilities119,285134,30372,47592,39295,102
Net assets / total equity212,315269,149346,461343,801358,376
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CLINICAL DIRECTOR SOLUTIONS LTD

Company

CLINICAL DIRECTOR SOLUTIONS LTD is a private limited company registered with Companies House under company number 07155983. It was incorporated on 12 Feb 2010. Its status is active. The registered office is in London (W1W). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files abridged accounts (unaudited). Net assets were £358,376, up 4.2% on the previous year. Cash at bank and in hand was £434,760. Total assets were £453,478 and total liabilities £95,102. The company had an average of 1 employee. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

The company has 1 current director. One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2027. The next confirmation statement is due by 26 Feb 2027.